Description
Claira (Estradiol Valerate, Dienogest) Coated Tablets №28
Ingredients:
Each tablet contains:
- Estradiol Valerate
- Dienogest
Mechanism of Action:
Claira tablets work by combining estradiol valerate and dienogest to suppress ovulation, provide contraceptive protection, and regulate the menstrual cycle.
Pharmacological Properties:
Through its hormonal composition, Claira exhibits estrogenic and progestogenic effects, contributing to its contraceptive and acne management properties.
Indications for Use:
Claira tablets are indicated for:
- Contraception
- Regulation of the menstrual cycle
- Management of moderate acne
Contraindications:
Do not use Claira tablets if:
- You are pregnant or breastfeeding
- You have a history of thromboembolic disorders
- You have liver disease
Side Effects:
Common side effects of Claira may include nausea, headache, breast tenderness, and breakthrough bleeding. Contact your healthcare provider if you experience severe or persistent side effects.
Usage Instructions:
The recommended dosage is one tablet daily for 28 days. Take the tablet at the same time each day with water.
Benefits Compared to Analogues:
Claira has shown superior cycle control and tolerability compared to other oral contraceptives, making it an effective choice for contraception and menstrual cycle regulation.
Suitable Patient Groups:
Claira is suitable for adult women seeking contraception, menstrual cycle regulation, and acne management. Consult a healthcare provider for use in specific patient groups such as adolescents, elderly individuals, or those with specific medical conditions.
Storage and Shelf Life:
Store Claira tablets in a cool, dry place away from direct sunlight and out of reach of children. Do not use the tablets after the expiration date printed on the packaging.
Packaging Description:
Claira tablets are packaged in a container with 28 coated tablets, each labeled with the product name and ingredients for easy identification.
Clinical Evidence and Proven Effectiveness:
Claira tablets have been extensively studied for their efficacy in contraception and menstrual cycle regulation. Research published in the Journal of Contraception demonstrated that the combination of estradiol valerate and dienogest effectively suppressed ovulation and provided reliable contraceptive protection.
Clinical trials have shown the superior cycle control and tolerability of Claira compared to other oral contraceptives. A study in the European Journal of Obstetrics & Gynecology and Reproductive Biology reported that Claira was well-tolerated and resulted in fewer breakthrough bleeding episodes.
